318 related articles for article (PubMed ID: 10545286)
1. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.
Wilson C; Hunt SJ; Tang E; Wright N; Kelly E; Palmer S; Heys C; Mellor S; James R; Bialecki R
J Pharmacol Exp Ther; 1999 Sep; 290(3):1085-91. PubMed ID: 10454481
[TBL] [Abstract][Full Text] [Related]
3. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
4. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.
Itoh H; Yokochi A; Yamauchi-Kohno R; Maruyama K
Eur J Pharmacol; 1999 Jul; 376(3):233-8. PubMed ID: 10448881
[TBL] [Abstract][Full Text] [Related]
5. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
6. A novel orally active endothelin-A receptor antagonist, ZD1611, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Stinson-Fisher C; Murdoch W; Bertelsen D; Desiato M; Rumsey W
Chest; 1998 Jul; 114(1 Suppl):91S. PubMed ID: 9676649
[No Abstract] [Full Text] [Related]
7. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
8. Chronic hypoxia increases staurosporine sensitivity of pulmonary artery smooth muscle to endothelin-1.
Bialecki RA; Fisher CS; Murdoch WW; Barthlow HG
Pulm Pharmacol Ther; 1998; 11(2-3):159-63. PubMed ID: 9918749
[TBL] [Abstract][Full Text] [Related]
9. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension.
Haleen S; Schroeder R; Walker D; Quenby-Brown E; Welch K; Hallak H; Uprichard A; Keiser J
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S331-5. PubMed ID: 9595473
[TBL] [Abstract][Full Text] [Related]
11. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.
Chen SJ; Chen YF; Meng QC; Durand J; Dicarlo VS; Oparil S
J Appl Physiol (1985); 1995 Dec; 79(6):2122-31. PubMed ID: 8847282
[TBL] [Abstract][Full Text] [Related]
13. [The effect of ETA receptor antagonist WS009A on the pathogenesis of hypoxic pulmonary hypertension in rats].
Yang X; Chen W
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):409-12. PubMed ID: 12536579
[TBL] [Abstract][Full Text] [Related]
14. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
[TBL] [Abstract][Full Text] [Related]
16. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Tan JX; Huang XL; Wang B; Fang X; Huang DN
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
[TBL] [Abstract][Full Text] [Related]
17. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
18. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
PriƩ S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
19. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]